Saturday, June 20, 2026

Emergent BioSolutions

April 1, 2021

Johnson & Johnson’s COVID-19 vaccine batch fails U.S. FDA quality test

Johnson & Johnson said it was still on track to deliver more than 20 million vaccine doses it promised the U.S.